Sermorelin

Sermorelin is a compounded sterile prescription peptide and is not FDA-approved. Do not use during pregnancy or breastfeeding, under age 18, with active cancer or a history of malignancy unless explicitly cleared by the appropriate specialist, severe respiratory impairment, acute respiratory failure, acute critical illness after major surgery or trauma, or known hypersensitivity to sermorelin or a formulation component. Disclose diabetic retinopathy, pituitary disease, endocrine disorders, all cancers, medications, and all medical conditions. Injection-site redness, pain, swelling, or pallor, headache, flushing, dizziness, nausea, restlessness, and rare swallowing difficulty may occur. Seek emergency care for trouble breathing, facial or throat swelling, fainting, severe rash, severe headache, neurologic symptoms, or signs of serious infection. Reconstitute only with the supplied or pharmacy-directed 6 mL bacteriostatic water using sterile technique; roll gently and do not shake. Store lyophilized powder according to the pharmacy label. Refrigerate immediately after mixing, protect from light, never freeze, and discard by the exact pharmacy-labeled BUD. Do not use if damaged, cloudy, unexpectedly discolored, or containing particles after reconstitution. Use only the prescribed 0.2 mL SubQ dose and 5-on/2-off schedule; never share needles or vials or change route/dose independently. Sermorelin is not HGH replacement, a steroid, a weight-loss drug, an anti-aging treatment, or a bodybuilding/performance product. No sleep, recovery, energy, muscle, fat-loss, collagen, bone, or performance result is guaranteed.